![]() ![]() ![]() "FDA approval of our first-ever therapy to slow the progression of geographic atrophy allows us to help patients who otherwise often have a relentlessly progressive form of AMD that can be visually debilitating as time goes on," - lead investigators Allen Chiang, MD, Mitchell S. With clinical study support leading up to the historic approval of pegcetacoplan, the specialists at Mid Atlantic Retina - part of the larger Will Eye Hospital team - continue demonstrating their commitment to ensuring individuals have access to the most advanced, effective treatments available. ![]() This includes involvement in clinical research programs investigating advances in surgical techniques, procedures, and pharmaceuticals. FDA approval of intravitreal pegcetacoplan came after three phases of clinical trials conducted over a 24-month period, with direct involvement by Mid Atlantic Retina (and Wills Eye Hospital) physicians during the phase 2 and crucial stage 3 clinical trial periods.Īs a Center for Excellence in treating retinal diseases, Mid Atlantic Retina provides patients with the latest in cutting-edge treatments and techniques for various retinal conditions. Food and Drug Administration (FDA), a groundbreaking new treatment for dry age-related macular degeneration (dry AMD) with geographic atrophy (GA). Physicians at Mid Atlantic Retina are proud to announce the approval of pegcetacoplan by the U.S. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |